Abstract. Insulin-like growth factor-I (IGF-I) in vivo or in the presence of other permissive factors can promote myelination in the central nervous system. In the current study, we examine the role of IGF-I in the myelination of peripheral nerves. In rat cocultures of dorsal root ganglia (DRG) and Schwann cells (SC) grown in serum-and insulin-free defined medium, IGF-I induces a dose dependent upregulation in myelin proteins such as P 0 , corresponding to maximal SC ensheathment. Furthermore, IGF-I is essential in promoting a dose-dependent, long-term myelination of DRG sensory axons. In the absence of IGF-I, axons and SC survive, but fail to myelinate. In the presence of 10 nM IGF-I, 59% of axons are myelinated at 21 days, whereas in the absence of IGF-I myelination fails to occur. Maximum SC ensheathment occurs 48 hours after addition of IGF-I. If IGF-I is withdrawn at 48 hours, axon segregation by SC persists, however, most axons and SC do not exhibit a oneto-one relationship and little myelination is observed. IGF-I is important in myelination and is critical not only for initial SC ensheathment of the axon and upregulation of myelin proteins, but also for sustained myelination. Furthermore, IGF-I associated axonal size is not the sole determinant for myelination.
INTRODUCTION
Insulin-like growth factor-I (IGF-I) is a critical factor in central nervous system (CNS) myelination in vivo. In organotypic CNS cultures, IGF-I promotes myelination of axons by oligodendrocytes (1) . In IGF-I overexpressing mice, myelin content in the brain is 30% greater than controls and their brains are 55% larger (2) . These transgenic animals also have a larger number of myelinated axons when compared with normal littermates (2) . In parallel, mice that overexpress the IGF-I inhibitor, insulinlike growth factor binding protein-1 (IGFBP-1), have a significantly decreased number of CNS myelinated axons with thinner myelin sheaths (3) . Likewise, disruption of the IGF-I gene results in CNS hypomyelination and a decrease in size of white matter tracts (4) .
Despite these findings in CNS neurons and glia, little is known about the role of IGF-I in peripheral nervous system (PNS) myelination. We have reported in cocultures of rat dorsal root ganglia (DRG) and Schwann cells (SC), IGF-I promotes SC migration and the attachment of SC to axons (5, 6) . In the PNS, SC differentiate into a myelinating phenotype following axonal contact, and express myelin-specific proteins such as P 0 . IGF-I enhances P 0 expression in cultured SC, grown in the presence of cAMP to simulate the presence of axons (7) . These data suggest that IGF-I may promote not only the initial interactions between SC and axons, but also longterm myelination. In support of this idea, the IGF-I receptor (IGF-IR) is expressed by both late embryonic and adult rat SC and axons (8) . Recent studies in IGF-I transgenic animals show reduction in conduction velocities in IGF-I Ϫ/Ϫ and Ϫ/ϩ mice, corrected by addition of IGF-I (9).
In the current study, we examined the effects of IGF-I on long-term PNS myelination. Using rat DRG/SC cocultures maintained in a defined serum-and insulin-free media, we report that with continued IGF-I exposure there is upregulation of myelin-specific genes leading ultimately to long-term myelination of peripheral axons. While other permissive factors may be necessary for optimal myelination, in the absence of IGF-I myelination fails to occur. The critical effects of this growth factor in axonal myelination suggest that IGF-I is important in PNS development and myelination.
MATERIALS AND METHODS

Cell Culture Media
DRG cultures were maintained in one of the following media: a serum-and insulin-free defined medium (SIFDM), standard myelinating medium (SMM), or SIFDM with 30 M 5-fluoro-2Ј-deoxyuridine (FUDR; Sigma, St. Louis, MO).
SIFDM contained the following: neurobasal medium supplemented with 2.5 mg/ml 99% pure bovine serum albumin (BSA), 2.56 g/ml catalase, 1 g/ml reduced glutathione, 2.5 g/ml superoxide dismutase, 10 g/ml transferrin, 0.002 g/ml triiodothyronine (all added fresh), 0.1 g/ml biotin, 1 g/ml ethanolamine, 15 g/ml D-galactose, 1 g/ml linoleic acid, 0.2 g/ ml retinol acetate, 2 g/ml L-carnitine, 1 g/ml linolenic acid, 0.006 g/ml progesterone, 16 g/ml putrescine, 1.4 mM Lglutamine, 5 mM glucose (total 30 mM), 30 nM selenium, 10 nM hydrocortisone, 10 nM ß-Estriadiol, 2 g/ml alpha-tocopherol, and 50 g/ml ascorbic acid. Catalase and superoxide dismutase were included in the medium to reduce excitotoxic-induced neuronal death after initial plating (10) . All components were obtained from Sigma, except for neurobasal medium from Gibco (Grand Island, NY) and 2.5S NGF from Bioproducts for Science (Madison, WI). IGF-I (gift from Cephalon Inc, Cephalon, West Chester, PA) 1-10 nM was added to SIFDM to obtain myelination.
SMM contained 10% heat inactivated fetal bovine serum (FBS; Hyclone Laboratories, Logan, UT), 50 g/ml ascorbic acid, 10 ng/ml 2.5S NGF, 1.4 mM L-glutamine, 30 mM glucose, and Eagle's Minimal Essential Medium (EMEM; Gibco). Earlier experiments in this laboratory indicated that optimal neurite growth was obtained with 10 ng/ml NGF and equal myelination was obtained with 10% and 15% FBS from the same batch number (data not shown).
DRG and SC Culture
Dissociated DRG from 15-day-old embryonic (E15) Sprague-Dawley rats (Harlan Sprague-Dawley, Madison, WI) were aseptically plated on air dried, single, fresh, collagen coated ACLAR dishes as previously described (11, 12) , and were incubated at 37ЊC with 5% carbon dioxide. Dissociated DRG were prepared by incubating the whole DRG in 0.05% trypsin (Gibco) for 40 minutes (min) at 37ЊC, centrifuging at 800 ϫ g for 5 min, followed by trypsin removal. The cells were washed in EMEM, followed by gentle titration through a Pasteur pipet with a flame-narrowed tip. To reduce the number of contaminating SC and fibroblasts, neurons were preplated on positively charged Primaria plates (Falcon, Franklin Lakes, NJ) for 45 min, which reduces the number of non-neuronal cells from 3 to 0.1% (13) . The dissociated DRG neurons were plated at a density of approximately 20,000 neurons per ACLAR dish. For DRG-secondary SC cultures, dissociated DRG were cultured for 7 days in SIFDM with 30 m FUDR to remove any remaining endogenous SC or fibroblasts. The cultures were then washed with SIFDM and secondary SC were added to the dissociated axons. Secondary SC were isolated from 3-day-old rats and passaged in cell culture up to 7 times (14) . Approximately 100,000 secondary SC were added to dissociated axons. In separate experiments, SC transferred to the culture dish at the time of original plating were not removed, and endogenous SC cocultures were allowed to continue to myelinate in the presence of SIFDM Ϯ IGF-I.
Western Immunoblotting
To determine if IGF-I increases expression of major myelin associated proteins, immunoblotting for P 0 was performed on DRG-SC cocultures. DRG were cultured for 7 days in SIFDM with 30 M FUDR. The medium was replaced every 48 hours (h). After 7 days, the cultures were washed 3 times with SIFDM without FUDR, and then secondary SC and test medium were added. After a further 48 h, the cells were lysed and protein extracted as previously described (15) . Briefly, cocultures were rinsed with ice cold phosphate buffered saline (PBS), and lysed in lysis buffer (50 mM Tris-HCL, pH 7.4, 1% NP 40, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 g/ml aprotinin and leupeptin, 1 mM sodium orthovanadate, and 1 mM NaF). Western immunoblotting was performed by first separating DRG-SC proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE-12.5%) and then electrophoretically transferred to nitrocellulose. Equal protein (50 g) was loaded in each well. Nitrocellulose membranes were blocked with 5% nonfat dried milk in TBST buffer (20 mM Tris, 0.16 M NaCl, and 0.10% Tween-20 [pH 7.4]). The membranes were then incubated for 2 h with 1:1000 mouse monoclonal anti-P 0 antibody (P 0 7)-a gift from Dr. Juan J. Archelos, Max-Planck-Institute for Psychiatry, Munich, Germany. The membranes were washed in TBST and incubated for 1 h with horseradish peroxidase-conjugated anti-mouse secondary monoclonal antibody at a concentration of 1:1000 (Santa Cruz, Santa Cruz, CA). Immunoreactive protein was detected with enhanced chemiluminescence (ECL) reagents (Pierce, Rockford, IL).
Measurement of Myelination
At 21 days, the DRG-SC cocultures were washed with 0.15 M cacodylate buffer, fixed in Trumps fixative (1% glutaraldehyde and 4% formaldehyde in 0.1 M cacodylate buffer), stained with 2% osmium for 1 h, dehydrated through increasing alcohol concentrations, and then stained with Sudan black (Sigma) in 70% ethanol for 1 h.
In order to assess overall myelination in the culture, we measured Sudan black stained myelinated axons. Using a grid system and a random number generator (16) cultures stained with Sudan black were photographed using a video imaging system (Sony, Sony Corp., Japan) linked to a Nikon microscope using a 100ϫ objective (Nikon, Japan). Photographs were obtained in a random fashion, with the observer blinded to the treatment. Using minor modifications of a previously published technique (17), we determined the percentage of normally myelinated fibers per imaging field from 100 fibers per section. Myelinated fibers were only measured if at least 1 fully myelinated internode was present. The measurements were only on myelinated fibers. The results indicate the percentage of normally myelinated fibers with at least 1 fully myelinated internode compared with all fibers showing evidence of myelination, i.e. incompletely myelinated internodes.
For further assessment of myelination in IGF-I-treated cultures, semithick sections (0.75 m) were obtained from glutaraldehyde fixed cultures as described above. The sections were stained with para-phenylene diamine as previously described (18) . The slides were then graded by a technician blinded to the experimental condition. Video enhanced images of each slide were collected using a video imaging system linked to a Nikon microscope with a motorized stage, and a Hamamatsu CCD camera (Hamamatsu, Japan). Image One imaging software (Universal Imaging, PA) was used to analyze the samples and individual imaging tiles from the whole section were digitally combined to form a composite image of each section. The following parameters were measured: centroid X and Y coordinates, myelinated axon area, axon area, axon diameter, perimeter, section area, chord angle and longest chord using similar sampling parameters to Windebank and colleagues (19) . From this database we calculated the mean myelinated axon density obtained from the mean of all frame axon densities, myelinated axon area (m Fig. 1. P 0 protein expression was increased by increasing concentrations of IGF-I. DRG-secondary SC cocultures were grown for 48 h in SIFDM alone or SIFDM with 1-10 nM IGF-I. Equal protein (50 g) was loaded in each well and samples were separated by SDS-PAGE followed by immunoblotting with P 0 antibody. In the presence of SIFDM alone (lane 1), P 0 protein expression was minimal, but increased in a dose dependent manner with increasing concentrations of IGF-I (lanes 2 to 4 and graph).
cacodylate buffer, pH 7.2, followed by 1 h postfixation in 1% OsO4. After rinsing in 3 changes of distilled water for 30 min, the tissue was en bloc stained with 2% uranyl acetate for 30 min at 60ЊC. After en bloc staining, the tissue was rinsed once in distilled water, dehydrated in progressive concentrations of ethanol, washed in 100% propylene oxide, and embedded in Spurr's resin. Thin (90 nm) sections were cut perpendicular to the plane of axon growth, placed on slot copper grids and stained with lead citrate. All chemicals were obtained from Electron Microscopy Services (Ft. Washington, PA). Photographs were taken with the operator unaware of the treatment condition, using a Phillips CM100 transmission electron microscope operating at 60 kV. Images were stored digitally.
Measurement of Unmyelinated Axons
TEM sections were prepared as above, imaged at 30,000 magnification, stored digitally, and analyzed using a semi-automated image analysis program. The number, area, and diameter of myelinated axons were calculated from separate digital tiles randomly obtained from 12 slot grids/condition. Each digital tile was checked for measurement consistency by an operator unaware of the treatment condition.
Statistical Analysis
Assumptions about the Gaussian distribution of data were made using normalized cumulative frequency polygons and determination of the skewness and kurtosis of data. Since most data measuring myelinated or unmyelinated axon parameters do not follow a Gaussian distribution, comparison of dependent variables was performed using nonparametric measures of significance. Inference was made using a probability less than the 0.05 level. For graphic and descriptive purposes, data is expressed in percentage Ϯ standard error of the mean, median, and range of values.
RESULTS
IGF-I Increases P 0 Protein Expression in DRG-SC Cocultures
In order to determine if IGF-I increased the expression of P 0 in DRG/SC cocultures, we treated cultures with increasing concentrations of IGF-I (1-10 nM). We previously found that maximum SC attachment was present at 48 h (5, 6), and chose this as the optimal time point for studying P 0 protein expression. Immunoblots showed an increase in P 0 protein expression at 48 h in a dose dependent manner (Fig. 1) . Densitometry based on scanned pixel density revealed at least a 100% increase in P 0 protein expression with 1 nM IGF-I and a 400% increase with 10 nM IGF-I (Fig. 1, graph) . Similar changes were observed at 24 h (data not shown), but P 0 expression was not as distinctly increased at this time point.
IGF-I Induces Myelination in Axon-SC Cocultures
Myelination within cocultures may vary between the center of the culture and the periphery where neurites are still growing. In order to evaluate myelination in the whole culture, we determined the percentage of fully myelinated fibers as described in the Materials and Methods section and found that myelination was increased in the presence of IGF-I (Figs. 2, 3 ). Using previously described methods (17), we compared completely myelinated axons, with at least 1 fully myelinated internode to all fibers showing evidence of incomplete myelination of internodes. Although myelinated fibers are usually easily recognized using this technique, we adjusted for counting in heavily myelinated sites as previously described (17) . In cultures treated with SIFDM alone, axonal development appears normal although there are essentially no myelinated axons ( Fig. 2A) . Not only did 10 nM IGF-I in serum-and insulin-free conditions (SIFDM) induce myelination of DRG axons (Fig. 2B ), but segmental myelination with well-developed internodes and nodes of Ranvier were observed, similar to myelination in vivo in mammalian nerves. Although myelination was observed in SMM, myelination was less complete in individual axons and less extensive overall compared with IGF-I-treated cultures (Figs. 2C, 3 ).
In Figure 3 at least 30 fields were viewed in each experiment and greater than 100 myelinated axons were assessed, where myelination was present. Results were generated from at least 3 experiments, with standardization against controls. In the presence of either endogenous or secondary SC and SIFDM, there was no normal myelination. Even though axonal development was normal, there were no fully myelinated internodes, which are usually observed in standard serum containing myelination protocols at 21 days (17, 19, 20) . There was a dose dependent increase in the percentage of normally myelinated axons when comparing treatment with 1 nM IGF-I and 10 nM IGF-I ( Fig. 3 ; p Ͻ 0.05). Furthermore the percentage of normally myelinated axons was significantly greater with 10 nM IGF-I (59%) compared with SMM (33%; p Ͻ 0.001). Allowing myelination to occur in the presence of endogenous SC compared with secondary SC failed to induce full myelination of axons (Fig. 3) .
Myelination was further quantitated using semithin (0.75 m) sections from DRG-SC cocultures treated with SIFDM, 1 nM IGF-I, and 10 nM IGF-I. These sections provided detailed information about myelination in specific axons, usually near the center of the culture, but could not accurately assess overall myelination in the cultures. Between 15 and 36 sections were assessed in each condition. We confirmed that no loops of myelin were present in SIFDM cultures in the absence of IGF-I. Myelinated axons were present with 1 and 10 nM IGF-I. We found no significant difference in myelin thickness, axon area, or axon diameter between 1 nM IGF-I-and 10 nM IGF-I-treated cultures (Table) . The mean myelinated fiber density was greater with 10 nM IGF-I than with 1 nM IGF-I, however, this difference did not reach statistical significance (Table) .
In TEM sections we observed no myelinated axons with SIFDM alone, although many unmyelinated axons were present (Fig. 4) . Most SC retained an undifferentiated form, and there was little evidence of axonal-SC attachment or ensheathment. On gross appearance there was little difference in the unmyelinated axons in SIFDM alone (control) or in the presence of IGF-I. Neurofilament structure and organelles such as mitochondria were similar in both. Electron dense bodies were observed in both control and IGF-I-treated axons. In the presence of IGF-I there was formation of normal myelin. At higher magnification normal periodicity of the myelin as well as major dense lines between the loops of myelin were observed as in normal mammalian myelinated nerves (Fig. 4F) . Although most of the myelinated axons had a larger diameter and cross sectional area compared with nonmyelinated axons, smaller axons were also myelinated (Fig. 4F) . We used an area cutoff of 1 m 2 (95% of IGF-I-treated unmyelinated axons are smaller than 1 m 2 ) to determine differences in degree of myelination between large (Ͼ1 m 2 ) vs small (Ͻ1 m 2 ) axons. The mean myelin thickness for large axons was 1.84 Ϯ 0.38 m 2 and for small axons was 1.22 Ϯ 0.10 m 2 (NS), indicating that myelin thickness was greater overall in larger myelinated fibers. 
Long-Term Treatment of DRG-SC Cocultures Is Required for Optimal Myelination
In order to determine if IGF-I exposure was required only for initial ensheathment of axons following which myelination would proceed normally, we studied the effect of short term IGF-I exposure followed by IGF-I withdrawal. We had previously shown that axons were fully ensheathed by SC at 48 h, thus we chose to treat the cultures with IGF-I for 48 h and then withdraw IGF-I. Cocultures exposed to IGF-I for 48 h did show some myelination, however, the number of myelinated axons was considerably less than with continued exposure to IGF-I for 21 days (Figs. 5, 6 ). On TEM (Fig. 5) we observed that with continued IGF-I treatment a one-to-one relationship between SC and axons developed, with most unmyelinated axons being completely and individually ensheathed by a SC process. These axons, although not yet myelinated, had the histological appearance of early myelinating axons (Fig. 5A, B) . In contrast, if IGF-I was withdrawn after 48 h (the point of maximal SC ensheathment (5, 6), myelination of some axons occurred but the majority of the axons remained unmyelinated. SC processes extended between the unmyelinated axons, and enclosed groups of axons, however, the one-to-one relationship between SC and axon was absent (Fig. 5C, D) . In whole myelinated cultures in which IGF-I was withdrawn at 48 h, the percentage of fully myelinated axons was decreased to 8% compared with 56% with continuous IGF-I exposure for 21 days (Fig. 6) .
We then added IGF-I for varying periods of time during the continuous myelination period to determine time to IGF-I-induced myelination. Using semithin sections from timed experiments, we calculated the mean number of myelinated axons/mm 2 2 . This result was not statistically different from mean myelinated axon density after fixation at 21 days. These measurements indicate number of myelinated axons per section and are usually much less than the percentage of myelinated axons measured for whole myelinated cultures.
Effect of IGF-I on Unmyelinated Axon Diameter and Area
The axonal area and diameter of unmyelinated axons after 21 days exposure to SIFDM alone (control) or SIFDM and IGF-I was calculated from TEM sections (Fig. 7) . A total of 550 unmyelinated axons from 23 SIFDM digital tiles and 540 axons from 28 IGF-I-treated digital tiles were measured. The median control unmyelinated axon area is 0. m 2 ) and diameters (0.3-0.4 m) for SIFDM and 10 nM IGF-I are similar (Fig. 7) . Although there was a general shift to larger axons in IGF-I-treated as opposed to SIFDM-treated cultures, there is considerable crossover between SIFDM-treated and IGF-I-treated axons, with over 80% of IGF-I-treated axons falling within the area and diameter range of SIFDM axons. Only 12%-15% of IGF-I-treated unmyelinated axons have a larger axonal diameter or area than the largest SIFDM-treated axon. Furthermore, axonal size alone does not determine myelination since 10% of SIFDM unmyelinated axons are larger than the smallest IGF-I-treated myelinated axon, and 66% of IGF-I unmyelinated axons are larger than the smallest IGF-I-treated myelinated axon. 
DISCUSSION
Myelin gene expression is a good measure of SC differentiation (20) (21) (22) (23) . In the current study, P 0 protein expression was increased in a dose dependent fashion in SC-axonal cocultures exposed to IGF-I. Although P 0 expression was present at earlier time points, the levels were greatest at 48 h, corresponding to maximum SCaxon ensheathment. Even though both axons and SC were present, P 0 expression was absent in SIFDM without IGF-I. These data imply that in DRG-SC cocultures, axons, SC, and IGF-I are required in combination to induce P 0 expression. In agreement with our results, other laboratories have shown that in the presence of axonal contacts and serum, cultured SC express P 0 (20) (21) (22) (23) . Expression is also present in cultured SC in the absence of an axonal signal if a high concentration of serum is available (24) . Therefore, in both paradigms, serum that contains both IGF-I and cAMP is required for P 0 expression (23) (24) (25) (26) . In separate studies, SC remain undifferentiated and there is little expression of P 0 if only low concentrations of forskolin (a cAMP inducer) are present in a defined serum-free media (7, 27) . Treatment of SC with higher amounts of forskolin results in SC differentiation and myelin protein expression. We have also shown that IGF-I treatment of forskolin-treated SC further augments the expression of myelin proteins such as P 0 (5, 6, 24) . Collectively, these data suggest that IGF-I is synergistic with cAMP in SC and is critical for myelin gene expression.
In addition to enhancing initial SC axonal attachment and myelin gene expression, these results indicate that continued IGF-I treatment is essential for successful longterm myelination of axons in axon-SC cocultures. Up to 59% of the axons fully myelinate in the presence of IGF-I, using measurements of myelinated fibers in whole cultures. These results agree with work by Oudega and colleagues where IGF-I combined with platelet-derived growth factor (PDGF) enhanced myelination in the adult rat spinal cord (28) . Our data also clearly show that there is an IGF-I dose dependent increase in the number of myelinated axons based on calculations in whole cultures and in semithick sections. There are more myelinated axons in cultures treated with 10 nM IGF-I (59%) when compared with 1 nM IGF-I (45%) as measured in whole cultures. Using TEM measurements, the median myelinated fiber density with 1 nM IGF-I was approximately half that with 10 nM IGF-I, although the variability precluded reaching significance. This variability reflects uneven myelination, which is usually greater in the center of the culture and which may be biased by sampling a small area with TEM. Thus, measurement of total myelination in the culture using Sudan black staining provides a more complete and reproducible assessment of myelination. In parallel, we found that myelination with 10 nM IGF-I was greater than standard myelinating medium containing serum (33%), which has a lesser amount of IGF-I (5, 6). Our data suggest that IGF-I is one of the key permissive factors in serum necessary for optimal myelination. Recent studies have shown improvement in peripheral nerve conduction studies with addition of IGF-I (9). Interestingly, in IGF-I Ϫ/Ϫ and IGF-I Ϫ/ϩ animals there was no reduction in PNS myelination, although axon size was reduced. Interpretation of the role of IGF-I from these studies is limited by potential upregulation of the IGF-I R by IGF-II and insulin in vivo (3, 29) . Our study specifically limited these confounding variables.
We speculated that SC require continued IGF-I treatment throughout the 21-day period for successful myelination. To test this theory, IGF-I was withdrawn after 48 h, at which point SC-axonal ensheathment is complete. We then compared the degree of myelination between SC-axon cocultures treated for either 48 hours or 21 days with IGF-I. In both paradigms, in the first 48 h, IGF-I promotes both the segregation and ensheathment of unmyelinated axons i.e. axons were separated into bundles by ensheathing SC, a first step in myelination. These data suggest that acute IGF-I exposure initiates SC transformation into more mature myelinating cells and begins the process of myelination. We found that IGF-I exposure was needed for 21 days in order for most axons and SC to achieve a one-to-one relationship necessary to form an inner and outer mesaxon (30) , and to adequately myelinate. In comparison, if IGF-I was withdrawn at 48 h, a time point at which there is complete SC-axon attachment, many of the SC failed to develop a one-to-one relationship with a neighboring axon, reverted to an undifferentiated form, and myelination at 21 days was reduced. If IGF-I was discontinued after 21 days, cultures were equally myelinated for at least 1 more week.
Several possible explanations are possible for the reduced SC-axon ensheathment after IGF-I withdrawal. SC may lose contact with axons, lose the ability to express myelin proteins, and return to their immature phenotype. Alternatively, SC may stall at ensheathment and not proceed to myelination as has been observed in Krox-20 and SCIP transgenic mice (31, 32) . In these mutant animals, P 0 and MBP are not expressed normally and myelin compaction fails to occur, consistent with the role of P 0 in stabilizing myelin (24) . Interestingly, we found that only 48 h of IGF-I treatment was sufficient for successful 21-day myelination in a very small number of axons. These results suggest that once ensheathment is complete and there is sufficient upregulation of myelin specific proteins, myelination can occur, albeit at a substantially reduced rate.
Our data demonstrating successful IGF-I mediated long-term myelination in the PNS is in agreement with the reported role of IGF-I in the CNS (2, 4). IGF-I enhances CNS myelination in vitro (1) and overexpressing IGF-I transgenic mice have 30% more CNS myelin than their littermate controls (2) . IGF-I treatment of animals with CNS demyelinating disorders, such as experimental allergic encephalomyelitis (EAE), decreases demyelination, enhances remyelination, and reduces clinical deficits (33) (34) (35) . In our studies as well as work done in the CNS (1), the effect of IGF-I on myelination is likely to be due to activation of the IGF-I receptor rather than the insulin receptor. The concentrations of IGF-I needed for successful myelination (1-10 nM) are within the known Km for the IGF-I receptor (up to 1 nM) and well below the concentration necessary to activate insulin receptors (see (29) for review).
While it is clear from our data that IGF-I plays a pivotal role in PNS myelination, it was uncertain whether IGF-I-induced myelination by directly affecting IGF-I receptors on SC or indirectly by altering axonal caliber. Other reports have suggested that myelination can determine the caliber of DRG axons when cultured in serum containing myelinating medium (19) . This increase in axonal diameter is attributed to phosphorylation of axon neurofilaments during initiation of myelination, as has been observed in DRG-SC cocultures and in Trembler mouse sciatic nerves (36) . In the current study, there is considerable overlap of axonal area and diameter between treatment groups, as well as between unmyelinated and myelinated axons. For example, many of the unmyelinated axons in the IGF-I-treated cultures were larger than the smallest myelinated axon from the same cultures. In fact, with IGF-I treatment, 65% of the unmyelinated axons were larger than the smallest myelinated axon, although as expected median axon areas and diameters were generally greater in myelinated axons. These data suggest that IGF-I-induced myelination is independent of axon diameter. Furthermore we did not find that IGF-I preferentially myelinates small compared with large axons. In parallel, we also see that most of the unmyelinated axons treated with IGF-I are ensheathed by SC, even though myelination has not yet occurred. This ensheathment may increase phosphorylation of neurofilaments in the unmyelinated axon and lead to a later increase in axonal area and diameter. Our findings are supported by reports in the IGF-I overexpressing mouse where both large and small axons are ensheathed and myelinated in the presence of IGF-I (3, 37). Thus, even though axon size in the presence of IGF-I can be greater, this fact alone is unlikely to account for the increased rate of myelination in IGF-I-treated cultures compared with controls.
In summary, these results indicate that IGF-I in vitro upregulates specific myelin proteins such as P 0 , and that prolonged IGF-I exposure leads to successful myelination of axons with varying caliber. In the absence of IGF-I, SC and axons survive but fail to myelinate despite the presence of other permissive myelination factors. Our data suggests IGF-I plays an important role in PNS myelination.
